DK3383402T3 - Farmaceutisk sammensætning, der omfatter darunavir, og fremgangsmåde til fremstilling deraf - Google Patents
Farmaceutisk sammensætning, der omfatter darunavir, og fremgangsmåde til fremstilling deraf Download PDFInfo
- Publication number
- DK3383402T3 DK3383402T3 DK16808570.2T DK16808570T DK3383402T3 DK 3383402 T3 DK3383402 T3 DK 3383402T3 DK 16808570 T DK16808570 T DK 16808570T DK 3383402 T3 DK3383402 T3 DK 3383402T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- pharmaceutical composition
- composition including
- darunavir
- including darunavir
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- AIDS & HIV (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20150100526A GR1008965B (el) | 2015-12-02 | 2015-12-02 | Φαρμακευτικο σκευασμα που περιλαμβανει δαρουναβιρη και μεθοδος παρασκευης αυτου |
| PCT/EP2016/025158 WO2017092874A1 (en) | 2015-12-02 | 2016-11-30 | Pharmaceutical composition comprising darunavir and method for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3383402T3 true DK3383402T3 (da) | 2021-06-28 |
Family
ID=57517848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16808570.2T DK3383402T3 (da) | 2015-12-02 | 2016-11-30 | Farmaceutisk sammensætning, der omfatter darunavir, og fremgangsmåde til fremstilling deraf |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP3383402B1 (da) |
| CY (1) | CY1124253T1 (da) |
| DK (1) | DK3383402T3 (da) |
| ES (1) | ES2875405T3 (da) |
| GR (1) | GR1008965B (da) |
| HR (1) | HRP20210969T1 (da) |
| HU (1) | HUE054502T2 (da) |
| LT (1) | LT3383402T (da) |
| PL (1) | PL3383402T3 (da) |
| PT (1) | PT3383402T (da) |
| RS (1) | RS61955B1 (da) |
| SI (1) | SI3383402T1 (da) |
| SM (1) | SMT202100362T1 (da) |
| WO (1) | WO2017092874A1 (da) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4912309B2 (ja) * | 2004-09-02 | 2012-04-11 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ４−［［４−［［４−（２−シアノエテニル）−２，６−ジメチルフェニル］アミノ］−２−ピリミジニル］アミノ］ベンゾニトリルの塩酸塩 |
| GB201118182D0 (en) * | 2011-10-21 | 2011-12-07 | Jagotec Ag | Improvements in or relating to organic compounds |
| US9643976B2 (en) * | 2012-01-18 | 2017-05-09 | Aurobindo Pharma Ltd. | Solvates of darunavir |
-
2015
- 2015-12-02 GR GR20150100526A patent/GR1008965B/el active IP Right Grant
-
2016
- 2016-11-30 ES ES16808570T patent/ES2875405T3/es active Active
- 2016-11-30 DK DK16808570.2T patent/DK3383402T3/da active
- 2016-11-30 SM SM20210362T patent/SMT202100362T1/it unknown
- 2016-11-30 WO PCT/EP2016/025158 patent/WO2017092874A1/en not_active Ceased
- 2016-11-30 PT PT168085702T patent/PT3383402T/pt unknown
- 2016-11-30 LT LTEP16808570.2T patent/LT3383402T/lt unknown
- 2016-11-30 PL PL16808570T patent/PL3383402T3/pl unknown
- 2016-11-30 RS RS20210721A patent/RS61955B1/sr unknown
- 2016-11-30 HU HUE16808570A patent/HUE054502T2/hu unknown
- 2016-11-30 HR HRP20210969TT patent/HRP20210969T1/hr unknown
- 2016-11-30 EP EP16808570.2A patent/EP3383402B1/en active Active
- 2016-11-30 SI SI201631226T patent/SI3383402T1/sl unknown
-
2021
- 2021-06-23 CY CY20211100557T patent/CY1124253T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT3383402T (pt) | 2021-06-04 |
| HRP20210969T1 (hr) | 2021-09-17 |
| GR1008965B (el) | 2017-02-28 |
| EP3383402B1 (en) | 2021-03-24 |
| CY1124253T1 (el) | 2022-07-22 |
| SMT202100362T1 (it) | 2021-07-12 |
| ES2875405T3 (es) | 2021-11-10 |
| SI3383402T1 (sl) | 2021-08-31 |
| PL3383402T3 (pl) | 2021-10-18 |
| RS61955B1 (sr) | 2021-07-30 |
| LT3383402T (lt) | 2021-06-25 |
| WO2017092874A1 (en) | 2017-06-08 |
| HUE054502T2 (hu) | 2021-09-28 |
| EP3383402A1 (en) | 2018-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3453707T3 (da) | Benzazepinderivat, fremgangsmåde til fremstilling, farmaceutisk sammensætning og anvendelse deraf | |
| DK3486242T3 (da) | Oxopicolinamidderivat, fremgangsmåde til fremstilling deraf og farmaceutisk anvendelse deraf | |
| DK3312177T3 (da) | Tricyklisk derivatforbindelse, fremgangsmåde til at fremstille samme og farmaceutisk sammensætning omfattende samme | |
| DK3214081T3 (da) | Isoindolinderivat, mellemprodukt, fremgangsmåde til fremstilling, farmaceutisk sammensætning og anvendelse deraf | |
| DK3386484T3 (da) | Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler | |
| DK3354649T3 (da) | Oxaspiroderivat, fremstillingsmetode derfor og anvendelser deraf i lægemidler | |
| DK3303386T3 (da) | Anti-Tau-antistoffer og fremgangsmåder til anvendlelse | |
| DK3317284T3 (da) | Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse | |
| DK3557998T3 (da) | Sammensætninger, kompositioner og anvendelsesmetoder | |
| DK3559000T3 (da) | Benzimidazol-derivater, fremgangsmåder til fremstilling og anvendelser deraf | |
| DK3381469T3 (da) | Anti-erbb2 antistoflægemiddelskonjugat og sammensætning deraf, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| DK3404024T3 (da) | Quinazolinonderivat, fremgangsmåde til fremstilling deraf, farmaceutisk sammensætning og anvendelser | |
| DK3305310T3 (da) | Onkolytisk virusformulering og fremgangsmåde til fremstilling deraf | |
| DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
| DK3271347T3 (da) | Antifungale forbindelser og fremstillingsfremgangsmåder | |
| DK3233111T3 (da) | Farmaceutisk sammensætning, der omfatter plasminogen, og anvendelser deraf | |
| DK3380525T3 (da) | Farmaceutiske formuleringer og fremgangsmåder til anvendelse deraf | |
| DK3551619T3 (da) | Sammensætninger, der omfatter methylphenidat-prodrugs, fremgangsmåder til fremstilling og anvendelse heraf | |
| DK3357343T3 (da) | Fedtsammensætning og fremgangsmåde til fremstilling heraf | |
| DK3319609T3 (da) | Sammensætninger og fremgangsmåder til anvendelse af antibakterielle lægemiddelkombinationer | |
| DK3288379T3 (da) | Peptidsammensætninger og anvendelsesmåder | |
| DK3315181T3 (da) | Sammensat emne og fremgangsmåde til at fremstille samme | |
| DK3236934T3 (da) | Farmaceutisk sammensætning, fremstilling og anvendelser deraf | |
| DK3398598T3 (da) | Sulfonamidderivat og fremstillingsmetode og anvendelse deraf | |
| DK3360863T3 (da) | Etomidatderivat og mellemprodukt, fremgangsmåde til fremstilling og anvendelse deraf |